1. Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial
- Author
-
Parra, Edwin Roger, primary, Zhang, Jiexin, additional, Duose, Dzifa Yawa, additional, Gonzalez-Kozlova, Edgar, additional, Redman, Mary W., additional, Chen, Hong, additional, Manyam, Ganiraju C., additional, Kumar, Gayatri, additional, Zhang, Jianhua, additional, Song, Xingzhi, additional, Lazcano, Rossana, additional, Marques-Piubelli, Mario L., additional, Laberiano-Fernandez, Caddie, additional, Rojas, Frank, additional, Zhang, Baili, additional, Taing, Len, additional, Jhaveri, Aashna, additional, Geisberg, Jacob, additional, Altreuter, Jennifer, additional, Michor, Franziska, additional, Provencher, James, additional, Yu, Joyce, additional, Cerami, Ethan, additional, Moravec, Radim, additional, Kannan, Kasthuri, additional, Luthra, Rajyalakshmi, additional, Alatrash, Gheath, additional, Huang, Hsin-Hui, additional, Xie, Hui, additional, Patel, Manishkumar, additional, Nie, Kai, additional, Harris, Jocelyn, additional, Argueta, Kimberly, additional, Lindsay, James, additional, Biswas, Roshni, additional, Van Nostrand, Stephen, additional, Kim-Schulze, Seunghee, additional, Gray, Jhanelle E., additional, Herbst, Roy S., additional, Wistuba, Ignacio I., additional, Gettinger, Scott, additional, Kelly, Karen, additional, Bazhenova, Lyudmila, additional, Gnjatic, Sacha, additional, Lee, J. Jack, additional, Zhang, Jianjun, additional, and Haymaker, Cara, additional
- Published
- 2024
- Full Text
- View/download PDF